In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57B1/6J mice

Journal of Neurochemistry

Volumn 84, Issue 6, 2003, Pages 1431-1441

  Brunzell, Darlene H ^a   Russell, David S ^a   Picciotto, Marina R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ribbicoff Research Laboratories   (United States)

Author keywords

Amygdala; Extracellular regulated protein kinase; Mitogen activated protein kinase; Nucleus accumbens; Prefrontal cortex; Tyrosine hydroxylase; Ventral tegmental area

Indexed keywords

COTININE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DRINKING WATER; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; PROTEIN TYROSINE KINASE; TYROSINE 3 MONOOXYGENASE;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUBSTANCE ABUSE; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ADMINISTRATION, ORAL; AMYGDALA; ANIMALS; COTININE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG ADMINISTRATION SCHEDULE; LIMBIC SYSTEM; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NICOTINE; NICOTINIC AGONISTS; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; TOBACCO USE DISORDER; VENTRAL TEGMENTAL AREA;

ANIMALIA; NICOTIANA TABACUM;

EID: 0037343956     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01640.x     Document Type: Article

References (82)

1. Barrot M., Olivier J. D., Perrotti L. I., DiLeone R. J., Berton O., Eisch A. J., Impey S., Storm D. R., Neve R. L., Yin J. C. et al. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl Acad. Sci. USA 99, 11435-11440.
2. Belluardo N., Mudo G., Blum M., Cheng Q., Caniglia G., Dell'Albani P. and Fuxe K. (1999a) The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain. Brain Res. Mol. Brain Res. 74, 98-110.
3. Belluardo N., Mudo G., Caniglia G., Cheng Q., Blum M. and Fuxe K. (1999b) The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. Neuroreport 10, 3909-3913.
4. Belluardo N., Mudo G., Blum M. and Fuxe K. (2000) Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 113, 21-34.
5. Benwell M. E., Balfour D. J. and Anderson J. M. (1988) Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247.
6. Berhow M. T., Hiroi N. and Nestler E. J. (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715.
7. Blum M., Wu G., Mudo G., Belluardo N., Andersson K., Agnati L. F. and Fuxe K. (1996) Chronic continuous infusion of (-) nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat. Neuroscience 70, 169-177.
8. Breese C. R., Marks M. J., Logel J., Adams C. E., Sullivan B., Collins A. C. and Leonard S. (1997) Effect of smoking history on [3H]nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282, 7-13.
9. Carlezon W. A. Jr, Thome J., Olson V. G., Lane-Ladd S. B., Brodkin E. S., Hiroi N., Duman R. S., Neve R. L. and Nestler E. J. (1998) Regulation of cocaine reward by CREB. Science 282, 2272-2275.
10. Carr D. B. and Sesack S. R. (2000) Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex. J. Comp. Neurol. 425, 275-283.
11. Carr L. A., Rowell P. P. and Pierce W. M. Jr (1989) Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem. Res. 14, 511-515.
12. Chang K. T. and Berg D. K. (2001) Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 32, 855-865.
13. Clarke P. B., Fu D. S., Jakubovic A. and Fibiger H. C. (1988) Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246, 701-708.
14. Dajas-Bailador F. A., Soliakov L. and Wonnacott S. (2002) Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J. Neurochem. 80, 520-530.
15. Dalley J. W., Thomas K. L., Howes S. R., Tsai T. H., Aparicio-Legarza M. I., Reynolds G. P., Everitt B. J. and Robbins T. W. (1999) Effects of excitotoxic lesions of the rat prefrontal cortex on CREB regulation and presynaptic markers of dopamine and amino acid function in the nucleus accumbens. Eur. J. Neurosci. 11, 1265-1274.
16. Damaj M. I. (2000) The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice. Eur J Pharmacol. 404, 103-110.
17. Davis S., Vanhoutte P., Pages C., Caboche J. and Laroche S. (2000) The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. Neurosci. 20, 4563-4572.
18. Dineley K. T., Westerman M., Bui D., Bell K., Ashe K. H. and Sweatt J. D. (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125-4133.
19. Due D. L., Huettel S. A., Hall W. G. and Rubin D. C. (2002) Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am. J. Psych. 159, 954-960.
20. Fenster C. P., Beckman M. L., Parker J. C., Sheffield E. B., Whitworth T. L., Quick M. W. and Lester R. A. (1999) Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55, 432-443.
21. Ferrari R., Le Novere N., Picciotto M. R., Changeux J. P. and Zoli M. (2002) Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur. J. Neurosci. 15, 1810-1818.
22. French S. J., Humby T., Homer C. H., Sofroniew M. V. and Rattray M. (1999) Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Brain Res. Mol. Brain Res. 67, 124-136.
23. Fu Y., Matta S. G., James T. J. and Sharp B. M. (1998) Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors. J. Pharmacol. Exp. Ther 284, 1188-1196.
24. Gaddnas H., Pietila K., Piepponen T. P. and Ahtee L. (2001) Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water. Pharmacol. Biochem. Behav. 70, 497-503.
25. Gooney M. and Lynch M. A. (2001) Long-term potentiation in the dentate gyrus of the rat hippocampus is accompanied by brain-derived neurotrophic factor-induced activation of TrkB. J. Neurochem. 77, 1198-1207.
26. Grady S. R., Murphy K. L., Cao J., Marks M. J., McIntosh J. M. and Collins A. C. (2002) Characterization of nicotinic agonist-induced dopamine release from synaptosomes prepared from four mouse brain regions. J. Pharmacol. Exp. Ther. 301, 651-660.
27. Griffiths J. and Marley P. D. (2001) Ca2+-dependent activation of tyrosine hydroxylase involves MEK1. Neuroreport 12, 2679-2683.
28. Halloran S. M. and Vulliet P. R. (1994) Microtubule-associated protein kinase-2 phosphorylates and activates tyrosine hydroxylase following depolarization of bovine adrenal chromaffin cells. J. Biol. Chem. 269, 30960-30965.
29. Hariharan M. and VanNoord T (1991) Liquid-chromatographic determination of nicotine and cotinine in urine from passive smokers: comparison with gas chromatography with a nitrogen-specific detector. Clin. Chem. 37, 1276-1280.
30. Hariharan M., VanNoord T. and Greden J. F. (1988) A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clin. Chem. 34, 724-729.
31. Haycock J. W. (1993) Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40. Neurochem. Res. 18, 15-26.
32. Haycock J. W., Ahn N. G., Cobb M. H. and Krebs E. G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl Acad. Sci. USA 89, 2365-2369.
33. Heyser C. J., Roberts A. J., Schulteis G. and Koob G. F. (1999) Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol: Clin. Exp. Res. 23, 1468-1476.
34. Hsu E. H., Schroeder J. P. and Packard M. G. (2002) The amygdala mediates memory consolidation for an amphetamine conditioned place preference. Behav. Brain Res. 129, 93-100.
35. Jentsch J. D., Olausson P., Nestler E. J. and Taylor J. R. (2002) Stimulation of protein kinase a activity in the rat amygdala enhances reward-related learning. Biol. Psych. 52, 111-118.
36. Kenny P. J., File S. E. and Rattray M. (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Mol. Brain Res. 85, 234-238.
37. Konu O., Kane J. K., Barrett T., Vawter M. P., Chang R., Ma J. Z., Donovan D. M., Sharp B., Becker K. G. and Li M. D. (2001) Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res. 909, 194-203.
38. Lev S., Moreno H., Martinez R., Canoll P., Peles E., Musacchio J. M., Plowman G. D., Rudy B. and Schlessinger J. (1995) Protein tyrosine kinase PYK2 involved in Ca (2+)-induced regulation of ion channel and MAP kinase functions. Nature 376, 737-745.
39. Lim J., Yang C., Hong S. J. and Kim K. S. (2000) Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors. Mol. Cell Biochem. 212, 51-60.
40. Maldonado R., Blendy J. A., Tzavara E., Gass P., Roques B. P., Hanoune J. and Schutz G. (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273, 657-659.
41. Meil W. M. and See R. E. (1997) Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav. Brain Res. 87, 139-148.
42. Messing R. O., Stevens A. M., Kiyasu E. and Sneade A. B. (1989) Nicotinic and muscarinic agonists stimulate rapid protein kinase C translocation in PC12 cells. J. Neurosci. 9, 507-512.
43. Misra K., Roy A. and Pandey S. C. (2001) Effects of voluntary ethanol intake on the expression of Ca(2+)/calmodulin-dependent protein kinase IV and on CREB expression and phosphorylation in the rat nucleus accumbens. Neuroreport 12, 4133-4137.
44. Mitchell S. N., Smith K. M., Joseph M. H. and Gray J. A. (1993) Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 56, 989-997.
45. Nakayama H., Numakawa T., Ikeuchi T. and Hatanaka H. (2001) Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. Neurochem. J. Neurochem. 79, 489-498.
46. Naquira D., Zunino E., Arqueros L. and Viveros H. (1978) Chronic effects of nicotine on catecholamme synthesizing enzymes in rats. Eur. J. Pharmacol. 47, 227-229.
47. Nestler E. J. (2000) Genes and addiction. Nat. Genet. 26, 277-281.
48. Nestler E. J. (2001) Molecular neurobiology of addiction. Am. J. Addict. 10, 201-217.
49. Nestler E. J. and Aghajanian G. K. (1997) Molecular and cellular basis of addiction. Science 278, 58-63.
50. Nisell M., Nomikos G. G., Hertel P., Panagis G. and Svensson T. H. (1996) Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22, 369-381.
51. Pagliusi S. R., Tessari M., DeVevey S., Chiamulera C. and. Pich E. M. (1996) The reinforcing properties of nicotine are associated with a specific patterning of c-fos expression in the rat brain. Eur. J. Neurosci. 8, 2247-2256.
52. Panagis G., Hildebrand B. E., Svensson T. H. and Nomikos G. G. (2000) Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Synapse 35, 15-25.
53. Pandey S. C., Roy A., Xu T. and Mittal N. (2001) Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain. J. Neurochem. 77, 943-952.
54. Patterson S. L., Pittenger C., Morozov A., Martin K. C., Scanlin H., Drake C. and Kandel E. R. (2001) Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron 32, 123-140.
55. Picciotto M. R., Brunzell D. H. and Caldarone B. J. (2002) Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13, 1097-1106.
56. Pich E. M., Pagliusi S. R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R. and Chiamulera C. (1997) Common neural substrates for the addictive properties of nicotine and cocaine. Science 275, 83-86.
57. Pontieri F. E., Tanda G., Orzi F. and Di Chiara G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255-257.
58. Roceri M., Molteni R., Fumagalli F., Racagni G., Germarelli M., Corsini G., Maggio R. and Riva M. (2001) Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum. J. Neurochem. 76, 990-997.
59. Salminen O., Seppa T., Gaddnas H. and Ahtee L. (1999) The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal. J. Neurosci. 19, 8145-8151.
60. Sambrook J., Fritsch E. F. and Maniatus T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, NY.
61. Schafe G. E., Atkins C. M., Swank M. W., Bauer E. P., Sweatt J. D. and LeDoux J. E. (2000) Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J. Neurosci. 20, 8177-8187.
62. Schroeder B. E., Binzak J. M. and Kelley A. E. (2001) A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues. Neuroscience 105, 535-545.
63. Schulteis G., Ahmed S. H., Morse A. C., Koob G. F. and Everitt B. J. (2000) Conditioning and opiate withdrawal. Nature 405, 1013-1014.
64. See R. E. (2002) Neural substrates of conditioned-cue relapse to drug-seeking behavior. Pharmacol. Biochem. Behav. 71, 517-529.
65. Self D. W., Genova L. M., Hope B. T., Barnhart W. J., Spencer J. J. and Nestler E. J. (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848-1859.
66. See R. E., Kruzich P. J. and Grimm J. W. (2001) Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharm. 154, 301-310.
67. Serova L., Danailov E., Chamas F. and Sabban E. L. (1999) Nicotine infusion modulates immobilization stress-triggered induction of gene expression of rat catecholamine biosynthetic enzymes. J. Pharmacol. Exp. Ther. 291, 884-892.
68. Shaywitz A. J. and Greenberg M. E. (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821-861.
69. Smith K. M., Mitchell S. N. and Joseph M. H. (1991) Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J. Neurochem. 57, 1750-1756.
70. Sparks J. A. and Pauly J. R. (1999) Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57B1/6 mice. Psychopharm. 141, 145-153.
71. Stein E. A., Pankiewicz J., Harsch H. H., Cho J. K., Fuller S. A., Hoffmann R. G., Hawkins M., Rao S. M., Bandettini P. A. and Bloom A. S. (1998) Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am. J. Psych. 155, 1009-1015.
72. Sweatt J. D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 1-10.
73. Taber M. T. and Fibiger H. C. (1995) Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15, 3896-3904.
74. Tahara S., Fukuda K., Kodama H., Kato T., Miyoshi S. and Ogawa S. (2001) Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes. J. Am. Col. Cardiol. 38, 1554-1563.
75. Taylor J. R., Punch L. J. and Elsworth J. D. (1998) A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharm. 138, 133-142.
76. Thiels E., Kanterewicz B. I., Norman E. D., Trzaskos J. M. and Klann E. (2002) Long-term depression in the adult hippocampus in vivo involves activation of extracellular signal-regulated kinase and phosphorylation of Elk-1. J. Neurosci. 22, 2054-2062.
77. Tuominen R. K., McMillian M. K., Ye H., Stachowiak M. K., Hudson P. M. and Hong J. S. (1992) Long-term activation of protein kinase C by nicotine in bovine adrenal chromaffin cells. J. Neurochem. 58, 1652-1658.
78. Valjent E., Corvol J. C., Pages C., Besson M. J., Maldonado R. and Caboche J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709.
79. Walters C. L. and Blendy J. A. (2001) Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J. Neurosci. 21, 9438-9444.
80. Wang J., Chen Y.-B., Zhu X.-N. and Chen R.-Z. (2001) Activation of p42/44 mitogen activated protein kinase pathway in long-term potentiation induced by nicotine in hippocampal CA1 region in rats. Acta Pharmacol. Sin. 22, 685-690.
81. Widnell K. L., Self D. W., Lane S. B., Russell D. S., Vaidya V. A., Miserendino M. J., Rubin C. S., Duman R. S. and Nestler E. J. (1996) Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276, 306-315.
82. Ying S. W., Futter M., Rosenblum K., Webber M. J., Hunt S. P., Bliss T. V. and Bramham C. R. (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 22, 1532-1540.